The Signal: Kivu Bioscience @nasdaq
The Signal: Kivu Bioscience  @nasdaq
Uploaded August 2026 | Updated November 2026, 3 hours ago
From breakthrough science to clinical milestones, Kivu Bioscience is advancing the future of oncology. Hear CEO Mohit Trikha discuss the company's innovative ADC platform and vision for improving cancer care on The Signal.
The Signal: Kivu BioscienceWaFd Bank CEO on the greatest opportunities for community banking ahead@SpaceX launches initial public offering on NasdaqINNIO Group celebrates listing day at Nasdaq MarketSiteA1R water celebrates its Nasdaq debutNasdaq Chair and CEO Adena Friedman calls for collaboration to fight financial crimeLime celebrates their IPO at Nasdaq.Bending Spoons becomes Nasdaq ListedPowering Tomorrow: How Nasdaq Indexes Are Fueling a Tech-Driven EconomyAllie K. Miller on communicating your goals to AI and having a goal-oriented mindsetWindward Bio celebrates its IPO at Nasdaq MarketSiteFactorial Energy Co-Founder and CEO Dr. Siyu Huang shares $FACs vision for the future of energy.
Nasdaq |

The Signal: Kivu Bioscience

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER